1. Home
  2. EYPT vs NPK Comparison

EYPT vs NPK Comparison

Compare EYPT & NPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EYPT
  • NPK
  • Stock Information
  • Founded
  • EYPT N/A
  • NPK 1905
  • Country
  • EYPT
  • NPK United States
  • Employees
  • EYPT N/A
  • NPK N/A
  • Industry
  • EYPT Biotechnology: Laboratory Analytical Instruments
  • NPK Ordnance And Accessories
  • Sector
  • EYPT Industrials
  • NPK Industrials
  • Exchange
  • EYPT Nasdaq
  • NPK Nasdaq
  • Market Cap
  • EYPT 741.0M
  • NPK 785.7M
  • IPO Year
  • EYPT N/A
  • NPK N/A
  • Fundamental
  • Price
  • EYPT $14.01
  • NPK $109.38
  • Analyst Decision
  • EYPT
  • NPK
  • Analyst Count
  • EYPT 0
  • NPK 0
  • Target Price
  • EYPT N/A
  • NPK N/A
  • AVG Volume (30 Days)
  • EYPT 659.8K
  • NPK 46.7K
  • Earning Date
  • EYPT 08-06-2025
  • NPK 08-08-2025
  • Dividend Yield
  • EYPT N/A
  • NPK 0.92%
  • EPS Growth
  • EYPT N/A
  • NPK 26.27
  • EPS
  • EYPT N/A
  • NPK 5.82
  • Revenue
  • EYPT $51,898,000.00
  • NPK $450,603,000.00
  • Revenue This Year
  • EYPT N/A
  • NPK N/A
  • Revenue Next Year
  • EYPT N/A
  • NPK N/A
  • P/E Ratio
  • EYPT N/A
  • NPK $18.68
  • Revenue Growth
  • EYPT 2.99
  • NPK 31.27
  • 52 Week Low
  • EYPT $3.91
  • NPK $69.80
  • 52 Week High
  • EYPT $14.37
  • NPK $110.83
  • Technical
  • Relative Strength Index (RSI)
  • EYPT 77.25
  • NPK 62.88
  • Support Level
  • EYPT $11.38
  • NPK $100.38
  • Resistance Level
  • EYPT $12.24
  • NPK $108.60
  • Average True Range (ATR)
  • EYPT 0.74
  • NPK 3.35
  • MACD
  • EYPT 0.13
  • NPK 0.25
  • Stochastic Oscillator
  • EYPT 89.80
  • NPK 89.82

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.

About NPK National Presto Industries Inc.

National Presto Industries Inc has an eclectic product portfolio consisting of household appliances, ammunition, and diapers. The company operates in three segments namely Defense, Housewares/Small Appliance, and Safety. The defense segment which is engaged in manufacturing 40mm ammunition, precision mechanical and electro-mechanical assemblies, and medium caliber cartridge cases; performs Load, Assemble, and Pack (LAP) operations on ordnance-related products for the U.S. Government and prime contractor. While Housewares/Small Appliance segment designs, markets, and distributes housewares and small electrical appliances; the safety segment provides safety technology empowering organizations and individuals to protect what is more important.

Share on Social Networks: